News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Foghorn Therapeutics Unveils Clinical Findings From Phase 1 Trial of FHD-286 in Metastatic Uveal Melanoma
Thursday, June 29, 2023Foghorn Therapeutics Inc Nasdaq FHTX has released data from a Phase dose escalation safety study of their drug candidate FHD in metastatic uveal melanoma mUM The study aimed to evaluate the safety and tolerability of FHD However the company has deci...
Amicus Therapeutics Unveils Newly Approved Pompe Disease Therapy in the European Union
Wednesday, June 28, 2023Amicus Therapeutics a biotechnology company dedicated to developing medicines for rare diseases has received approval from the European Commission EC for Opfolda miglustat mg capsules Opfolda is an enzyme stabilizer used in the treatment of lateonset...
UCB Receives FDA Approval for RYSTIGGO® (Rozanolixizumab-noli) to Treat Adults With Generalized Myasthenia Gravis
Wednesday, June 28, 2023UCB a global biopharmaceutical company has received FDA approval for RYSTIGGO rozanolixizumabnoli as a treatment for generalized myasthenia gravis gMG in adult patients who are antiacetylcholine receptor AchR or antimusclespecific tyrosine kinase MuS...
AC Immune Granted FDA Fast Track Designation for ACI-24.060, an Anti-amyloid-beta Active Immunotherapy, in the Treatment of Alzheimer's Disease
Wednesday, June 28, 2023AC Immune SA a biopharmaceutical company specializing in precision medicine for neurodegenerative diseases has announced that its antiamyloid beta Abeta active immunotherapy candidate ACI has received Fast Track designation from the US Food and Drug...
Avicanna and Medipharm Labs Enhance Collaborative Manufacturing Agreement for Avicanna's Proprietary SEDDS Technology Capsules in Canadian and Global Markets
Tuesday, June 27, 2023Avicanna Inc a biopharmaceutical company focused on plantderived cannabinoidbased products has announced an extension of its strategic manufacturing agreement with Medipharm Labs Inc The agreement aims to commercialize Avicannas proprietary cannabino...
Sernova Unveils Positive Updated Interim Phase 1/2 Clinical Results for the Cell Pouch System™ at the American Diabetes Association's 83rd Scientific Sessions
Tuesday, June 27, 2023Sernova Corp a clinicalstage company specializing in cell therapeutics has announced positive interim data from its ongoing Phase clinical trial of the Cell Pouch System in patients with type diabetes TD and severe hypoglycemia unawareness The anno...
Abbott and the American Diabetes Association Partner to Create Groundbreaking Therapeutic Nutrition Program for Individuals Living With Diabetes
Monday, June 26, 2023Abbott and the American Diabetes Association ADA have announced a collaboration to enhance the understanding of diabetes technology specifically continuous glucose monitoring CGM systems and their impact on decisionmaking for individuals with diabete...
Initial Patient Receives First Dose in Phase 2 MATISSE Trial Evaluating IPH5201 for Early Stage Lung Cancer
Monday, June 26, 2023Innate Pharma SA Euronext Paris IPH Nasdaq IPHA announced the initiation of the MATISSE Phase study NCT a multicenter singlearm trial evaluating neoadjuvant and adjuvant treatment for resectable early stage nonsmall cell lung cancer NSCLC patients T...
Phase 1 Clinical Trial of Amylin Analog ZP8396 by Zealand Pharma Reveals Promising Results at ADA Scientific Sessions
Monday, June 26, 2023Zealand Pharma AS Nasdaq ZEAL is a biotechnology company focused on discovering and developing innovative peptidebased medicines Recently the company announced that the results from a Phase a clinical trial of their longacting amylin analog ZP will b...
Moonlake Immunotherapeutics Achieves Significant Milestone With Positive Phase 2 Results for Nanobody® Sonelokimab in Hidradenitis Suppurativa
Monday, June 26, 2023MoonLake Immunotherapeutics MoonLake Nasdaq MLTX has released positive topline results from its global Phase MIRA trial which assessed the efficacy and safety of their Nanobody sonelokimab in patients with moderatetosevere hidradenitis suppurativa H...
